Study Identifies Low Sensitivity of Standard, Modified Two-Tiered Testing for Lyme Disease

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on April 23, 2026.

via HealthDay

THURSDAY, April 23, 2026 -- For patients with early infection with Lyme disease (LD), standard and modified two-tiered testing (STTT and MTTT) diagnostic algorithms have low sensitivity, according to a study published online April 21 in the Journal of Clinical Microbiology.

Elizabeth J. Horn, Ph.D., from the Lyme Disease Biobank in Portland, Oregon, and colleagues examined performance of STTT and MTTT algorithms using samples obtained from well-characterized patients with early LD. Performance of four U.S. Food and Drug Administration-cleared STTT or MTTT algorithms was compared using serum samples from 107 cases, 69 participants with a convalescent draw, and 144 endemic controls.

The researchers found that algorithm sensitivity ranged from 22 to 36 percent at the initial blood draw, with specificity ranging from 98 to 100 percent. Higher sensitivity was seen for MTTT versus STTT algorithms. One STTT algorithm was less sensitive than the other, while sensitivity did not differ between the MTTT algorithms. Discordance was seen between the algorithms; of the 45 samples classified as laboratory-confirmed, only 22 were positive using all algorithms evaluated. Among cases with a suspected erythema migrans skin lesion, the likelihood of positive two-tiered serology increased with longer lesion duration and/or when presenting with one or more constitutional symptom.

"This study demonstrates that common two-tiered Lyme tests, utilized for decades, often fail to detect early Lyme disease and are leaving patients behind, highlighting a critical need for improved medical education on the limitations of current diagnostics," Horn said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-24 02:02

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords